Leflunomide (Arava™) is a useful DMARD in Indian (Asian) patients: a clinic-based observational study of 1-year treatment
… ) classification criteria [10] and were naïve for LEF use. The eligibility to begin LEF was principally governed by (1) … Two non-diabetic patients developed a moderately severe glove and …..... Read More